ArticleSurgery today2024

Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery.

Masaru Takenaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.